Lancashire and South Cumbria Chemotherapy CRG
Chemotherapy CRG Chair: Dr David Eaton, Consultant Medical Oncologist, University Hospitals of Morecambe Bay NHS Trust
Secretary: Jo Stabler Oncology.secretaries@mbht.nhs.uk
CRG Group Contact: Rachel Ellis Rachel.Ellis@LTHTR.nhs.uk
The role and purpose of the Chemotherapy CRG is to improve the experience and outcomes of cancer care for chemotherapy patients in Lancashire & South Cumbria.
This involves consideration of strategies and plans for service improvement and service development across the patient pathway, incorporating all aspects of care at appropriate stages of the patient's journey. The aim is to achieve the best possible outcomes and best quality of life for all patients who use Acute Oncology services within the Network.
Members of the group will be responsible for feeding back information/decisions from the meetings to their clinical and managerial colleagues.
Chemotherapy CRG Key Documents
- Contingency plan for iQemo Oncology e-Prescribing System (Updated September 2020)
- TNM8 Classification of Malignant Tumours 8th edition
Chemotherapy CRG Clinical Guidelines
- LSCCA Network Guidelines For The Use of Aranesp v2 (June 2018)
- LSCCA Antiemetic Guidelines (Updated March 2020)
- LSCCA SACT Administration Policy v6.0 (Updated November 2020)
- LSCCA Extravasation Policy v70- (Updated December 2020)
- LSCCA Chemotherapy Deviation Policy v2 (Updated November 2021)
- LSCCA Chemo SOP v1.3 (Updated November 20201)